Innovation and the pharmaceutical industry : critical reflections on the virtues of profit / / edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett.
Saved in:
| Superior document: | Trends and conflicts |
|---|---|
| : | |
| TeilnehmendeR: | |
| Year of Publication: | 2008 |
| Language: | English |
| Series: | Conflicts and trends.
|
| Online Access: | |
| Physical Description: | viii, 245 p. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02759nam a2200445 a 4500 | ||
|---|---|---|---|
| 001 | 5003340016 | ||
| 003 | MiAaPQ | ||
| 005 | 20200520144314.0 | ||
| 006 | m o d | | ||
| 007 | cr cn||||||||| | ||
| 008 | 080305s2008 mau sb 001 0 eng | ||
| 010 | |z 2008010541 | ||
| 020 | |z 9780980209440 (hardcover : alk. paper) | ||
| 020 | |z 0980209447 (hardcover : alk. paper) | ||
| 035 | |a (MiAaPQ)5003340016 | ||
| 035 | |a (Au-PeEL)EBL3340016 | ||
| 035 | |a (CaPaEBR)ebr10233893 | ||
| 035 | |a (CaONFJC)MIL172653 | ||
| 035 | |a (OCoLC)923251603 | ||
| 040 | |a MiAaPQ |c MiAaPQ |d MiAaPQ | ||
| 050 | 4 | |a HD9665.5 |b .I55 2008 | |
| 082 | 0 | 4 | |a 338.4/791510973 |2 22 |
| 245 | 0 | 0 | |a Innovation and the pharmaceutical industry |h [electronic resource] : |b critical reflections on the virtues of profit / |c edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett. |
| 260 | |a Salem, MA : |b M & M Scrivener Press, |c c2008. | ||
| 300 | |a viii, 245 p. | ||
| 490 | 1 | |a Trends and conflicts | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis. | |
| 533 | |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 | |a Pharmaceutical industry. | |
| 650 | 0 | |a Drug development. | |
| 650 | 0 | |a Medical innovations. | |
| 650 | 0 | |a Medical policy |z United States. | |
| 650 | 0 | |a Drugs |x economics |z United States. | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Engelhardt, H. Tristram |q (Hugo Tristram), |d 1941- | |
| 700 | 1 | |a Garrett, Jeremy R. | |
| 710 | 2 | |a ProQuest (Firm) | |
| 830 | 0 | |a Conflicts and trends. | |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3340016 |z Click to View |